MetLife Investment Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $181K | Sell |
|
|||||
|
2024
Q1 | $1.54M | Sell |
|
|||||
|
2023
Q4 | $1.56M | Buy |
|
|||||
|
2023
Q3 | $716K | Hold |
|
|||||
|
2023
Q2 | $1.04M | Buy |
|
|||||
|
2023
Q1 | $742K | Hold |
|
|||||
|
2022
Q4 | $959K | Buy |
|
|||||
|
2022
Q3 | $815K | Hold |
|
|||||
|
2022
Q2 | $763K | Buy |
|
|||||
|
2022
Q1 | $881K | Buy |
|
|||||
|
2021
Q4 | $515K | Hold |
|
|||||
|
2021
Q3 | $468K | Hold |
|
|||||
|
2021
Q2 | $407K | Buy |
|